ADC Therapeutics SA (ADCT)
1.285
-0.02
(-1.15%)
USD |
NYSE |
Sep 09, 14:56
ADC Therapeutics Total Assets (Quarterly) : 279.38M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 279.38M |
| March 31, 2026 | 291.50M |
| December 31, 2025 | 323.94M |
| September 30, 2025 | 289.76M |
| June 30, 2025 | 321.56M |
| March 31, 2025 | 272.54M |
| December 31, 2024 | 321.98M |
| September 30, 2024 | 349.08M |
| June 30, 2024 | 371.78M |
| March 31, 2024 | 307.97M |
| December 31, 2023 | 354.78M |
| September 30, 2023 | 466.90M |
| June 30, 2023 | 507.30M |
| Date | Value |
|---|---|
| March 31, 2023 | 467.67M |
| December 31, 2022 | 490.86M |
| September 30, 2022 | 531.76M |
| June 30, 2022 | 520.46M |
| March 31, 2022 | 581.89M |
| December 31, 2021 | 617.97M |
| September 30, 2021 | 637.98M |
| June 30, 2021 | 464.39M |
| March 31, 2021 | 461.70M |
| December 31, 2020 | 513.69M |
| September 30, 2020 | 521.53M |
| June 30, 2020 | 373.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 9.176B |
| AC Immune SA | 186.45M |
| CRISPR Therapeutics AG | 2.651B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 507.58M |
| Shareholders Equity (Quarterly) | -228.20M |
| Debt to Equity Ratio | -0.5152 |
| Current Ratio | 3.031 |
| Net Debt Paydown Yield | 49.76% |